Targeted anti-interleukin-17 therapy for linear porokeratosis

Br J Dermatol. 2023 Oct 25;189(5):630-631. doi: 10.1093/bjd/ljad223.

Authors

Donglin Li¹, Kristin Technau-Hafsi¹, Katrin Giehl², Peter H Hoeger³, Cristina Has¹

Affiliations

¹ Department of Dermatology, Medical Center - University of Freiburg, Freiburg, Germany.
² Department of Dermatology, Ludwig Maximilian University of Munich, Munich, Germany.
³ Catholic Children's Hospital, Wilhelmstift, Hamburg, Germany.

PMID: 37406221
DOI: 10.1093/bjd/ljad223

No abstract available

MeSH terms

Humans
Interleukin-17* / antagonists & inhibitors
Porokeratosis* / drug therapy

Substances

Interleukin-17